Influenza

[11] *FDA FLUM, 1998, MOUNT VIEW

[12] CLINICAL EFFECTIVENESS OF INFLUENZA VACCINATION IN MANITOBA [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (16): : 1956 - 1961

[13] AGE DISTRIBUTION OF PATIENTS WITH MEDICALLY-ATTENDED ILLNESSES CAUSED BY SEQUENTIAL VARIANTS OF INFLUENZA A/H1N1 - COMPARISON TO AGE-SPECIFIC INFECTION-RATES, 1978-1989 [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 133 (03) : 296 - 304

[14] SERIOUS MORBIDITY AND MORTALITY ASSOCIATED WITH INFLUENZA EPIDEMICS [J]. EPIDEMIOLOGIC REVIEWS, 1982, 4 : 25 - 44

[15] Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (18) : 1336 - 1343

[16] Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza - Randomized controlled trials for prevention and treatment [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (13): : 1240 - 1246

[17] EMERGENCE AND APPARENT TRANSMISSION OF RIMANTADINE-RESISTANT INFLUENZA-A VIRUS IN FAMILIES [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (25) : 1696 - 1702

[18] INFLUENZA - VIROLOGY, EPIDEMIOLOGY, DISEASE, AND PREVENTION [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 1994, 10 : 31 - 44

[19] Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control [J]. VACCINE, 2000, 18 (18) : 1902 - 1909

[20] IMPACT OF INFLUENZA EPIDEMICS ON MORTALITY IN THE UNITED-STATES FROM OCTOBER 1972 TO MAY 1985 [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1987, 77 (06) : 712 - 716

[11] *FDA FLUM, 1998, MOUNT VIEW

[12] CLINICAL EFFECTIVENESS OF INFLUENZA VACCINATION IN MANITOBA [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (16): : 1956 - 1961

[13] AGE DISTRIBUTION OF PATIENTS WITH MEDICALLY-ATTENDED ILLNESSES CAUSED BY SEQUENTIAL VARIANTS OF INFLUENZA A/H1N1 - COMPARISON TO AGE-SPECIFIC INFECTION-RATES, 1978-1989 [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 133 (03) : 296 - 304

[14] SERIOUS MORBIDITY AND MORTALITY ASSOCIATED WITH INFLUENZA EPIDEMICS [J]. EPIDEMIOLOGIC REVIEWS, 1982, 4 : 25 - 44

[15] Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (18) : 1336 - 1343

[16] Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza - Randomized controlled trials for prevention and treatment [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (13): : 1240 - 1246

[17] EMERGENCE AND APPARENT TRANSMISSION OF RIMANTADINE-RESISTANT INFLUENZA-A VIRUS IN FAMILIES [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (25) : 1696 - 1702

[18] INFLUENZA - VIROLOGY, EPIDEMIOLOGY, DISEASE, AND PREVENTION [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 1994, 10 : 31 - 44

[19] Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control [J]. VACCINE, 2000, 18 (18) : 1902 - 1909

[20] IMPACT OF INFLUENZA EPIDEMICS ON MORTALITY IN THE UNITED-STATES FROM OCTOBER 1972 TO MAY 1985 [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1987, 77 (06) : 712 - 716